![PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/6d/05/aa/6d05aa63-7fb3-3882-5399-c65ec87b7b98/mza_6762318573830869526.jpg/100x100bb.jpg)
Professor Ian M. Adcock, PhD, FRSB, FBPhS, FERS - Navigating the Relationship Between Type 2 Inflammation and Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy
PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast
English - January 07, 2021 23:00 - 25 minutes - ★★★★ - 5 ratingsScience cme medical education cme credits peerview insession inreview immunology transplantation cne Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Go online to PeerView.com/KGQ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an asthma expert discusses the relationship between type 2 inflammation and moderate to severe asthma and the use of targeted biologic therapies as treatment. Upon completion of this activity, participants should be better able to: Explain the relationship between type 2 inflammation and moderate-to-severe asthma, biomarkers such as blood eosinophils, and other comorbid conditions, Identify patients with uncontrolled moderate-to-severe asthma who are eligible for targeted biologic therapies based on clinical characteristics of type 2 inflammation, Develop treatment plans for patients with uncontrolled moderate-to-severe asthma according to updated evidence-based guidelines and the latest clinical data on efficacy and safety regarding targeted biologic therapy.